Post by Merck
2,737,839 followers
Hear from one of our senior leaders, Paula Annunziato, Senior Vice President, Infectious Diseases and Vaccines, Global Clinical Development, Merck Research Laboratories, on our commitment to advancing infectious disease research, including respiratory syncytial virus (#RSV) disease in infants.
Video Content